Australia’s Nicotine Pouch Ban Raises a Bigger Question About Harm Reduction

Australia has long been recognised as a global leader in tobacco control. It pioneered plain packaging, high tobacco taxes, advertising restrictions and comprehensive smoking reduction strategies, yet questions remain about how effective some of these measures have been in delivering the outcomes promised. Its latest reforms, however, mark a significant turning point in nicotine policy.…

Beyond Tobacco: Why Risk Should Guide Nicotine Regulation

For decades, tobacco control policies have been built around a straightforward premise: products containing tobacco should be regulated as tobacco products. This approach made sense when cigarettes, cigars, and smokeless tobacco dominated the market. Today, however, the nicotine landscape has changed significantly. A growing range of smoke-free products, including nicotine pouches, electronic cigarettes, heated tobacco…

Beyond Legislation: The Next Challenge for the UK’s Tobacco and Vapes Act

The United Kingdom’s Tobacco and Vapes Act marks one of the most significant tobacco control reforms in a generation. By introducing a “smoke-free generation” policy and strengthening the regulation of tobacco and vaping products, the legislation establishes an ambitious framework for reducing smoking prevalence and protecting future generations. But passing legislation is only the beginning.…

Real-World Evidence: The Missing Piece in Nicotine Policy

For decades, nicotine regulation has been built upon laboratory science, toxicological assessments, and clinical research. These forms of evidence remain indispensable for understanding product chemistry, biological mechanisms, and potential health effects. Yet as smoke-free nicotine products continue to evolve, regulators are increasingly recognising that scientific evidence alone does not always explain how products perform in…

Nicotine Pouches Deserve Better Than One-Dimensional Narratives

Why Evidence Matters in Public Health Communication A recent article published by Stanford Medicine, “Nicotine Pouches: The Tobacco Industry’s Latest Ploy?”, raises legitimate concerns about nicotine addiction and youth uptake. These are important issues that deserve serious attention and are shared concerns across the public health community.  However, effective public health communication should present the…

Finland’s Plain Packaging Rules Mark Another Step in Europe’s Evolving Nicotine Pouch Regulation

From 1 August 2026, Finland will complete one of Europe’s most comprehensive regulatory frameworks for nicotine pouches as standardized plain packaging requirements become fully mandatory. The measures represent the final stage of amendments to Finland’s Tobacco Act that have progressively tightened controls on nicotine pouches since August 2025. For GINN, Finland’s approach is significant not…

Biomarkers and Nicotine Pouches: Why Measuring Exposure Matters for Evidence-Based Regulation

As nicotine pouches continue to emerge within tobacco harm reduction discussions, policymakers are increasingly faced with a fundamental question: how should the health risks of these products be assessed? Public debate often reduces the issue to a simple question of whether nicotine pouches are “safe” or “unsafe.” While understandable, this framing overlooks how modern toxicology…

When Misinformation Becomes a Public Health Risk: Why Accurate Communication About Smoke-Free Nicotine Products Matters

Public health policy depends on informed decision-making. Whether developing regulation, advising patients, or supporting smoking cessation, decisions are only as effective as the information on which they are based. When scientific evidence is misunderstood, selectively interpreted, or communicated without appropriate context, the consequences can extend beyond public debate and influence individual health behaviours. This challenge…

Supporting Women Who Struggle to Quit Smoking During Pregnancy: Why Evidence-Based Conversations Matter

Smoking during pregnancy remains one of the most significant preventable causes of adverse maternal and infant health outcomes worldwide. It increases the risk of miscarriage, placental complications, preterm birth, low birth weight, stillbirth, and sudden infant death syndrome, while also contributing to long-term health consequences for both mother and child. For healthcare professionals, the objective…